Page 26 - CIRN Annual Report 2017-18

CIRN | 2018 ANNUAL REPORT

LIST OF PUBLICATIONS, ABSTRACTS

AND PRESENTATIONS

CIRN uses an integrated approach to disseminating knowledge as well

as training. The network provides a highly collaborative, team-oriented

framework for delivering research impact.

CANADIAN NATIONAL VACCINE SAFETY NETWORK
• DM MacDougall, JM Langley, L Li, L Ye, D MacKinnon-Cameron, KA Top, SA McNeil, BA Halperin,
A Swain, JA Bettinger, E Dubé, G De Serres, SA Halperin, for the Canadian Immunization Research
Network. Knowledge, attitudes, beliefs, and behaviors of university students, faculty, and staff during a
meningococcal serogroup B outbreak vaccination program. Vaccine 2017;35(18):2520-2530.

• JM Langley, S Gantt, C Quach, J Bettinger, S Halperin, J Mutch, S McNeil, B Ward, D MacKinnon Cameron,
L Ye, K Marty, D Scheifele, J Alcantara , and the CANADIAN IMMUNIZATION RESEARCH NETWORK
(CIRN). Preparedness for and response to meningococcal outbreaks: preliminary results of a Canadian
Immunization Research Network (CIRN) randomized controlled trial of two schedules of 4CMenB vaccine
in adolescents and young adults. Meningitis and Septicemia in Children and Adults 2017. 14-15 November
2017. London, UK. The British Museum. Poster V19 and Platform presentation (selected as one of the top
fi ve abstracts).

CLINICAL TRIALS NETWORK

• MS ElSherif, C Brown, D MacKinnon-Cameron, L Li, T Racine, J Alimonti, Rudge TL, Sabourin C, Silvera
P, Hooper JW, Kwilas SA, Kilgore N, Badorrek C, Ramsey WJ, Heppner DG, Kemp T, Monath TP, Nowak
T, McNeil SA, Langley JM, Halperin SA, and the Canadian Immunization Research Network. Assessing
the safety and immunogenicity of recombinant vesicular stomatitis virus Ebola vaccine in healthy adults: a
randomized clinical trial. CMAJ. 2017; 189(24):E819-E827. PubMed PMID: 28630358.

• DM MacDougall, JM Langley, L Li, D MacKinnon-Cameron, K Top, SA McNeil, BA Halperin, A Swain, JA
Bettinger, SA Halperin. Knowledge, attitudes, beliefs, and behaviours of university students, faculty and
staff during a meningococcal serogroup B outbreak vaccination program. Vaccine. 2017;35(18):2520-2530.
PubMed PMID: 28347501.

• JM Langley, S Gantt, C Quach, SA Halperin, S McNeil, F Diaz-Mitoma, D Anderson. Induction of epithelial
cell-neutralizing antibodies against cytomegalovirus (CMV) in adults vaccinated with an enveloped virus-
like particle (eVLP) containing an optimized form of glycoprotein B for prophylactic vaccination against
CMV [abstract]. Poster presented at: 2017 International Society of Vaccines Congress; 2017 Oct 5–7; Paris,
France. Abstract 01.4.

• JM Langley, S Gantt, C Quach, J Bettinger, S Halperin, J Mutch, S McNeil, B Ward, D MacKinnon Cameron,
L Ye, K Marty, D Scheifele, J Alcantara, and the Canadian Immunization Research Network. Preparedness